BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/21/2025 9:40:07 AM | Browse: 56 | Download: 102
Publication Name World Journal of Clinical Oncology
Manuscript ID 101098
Country China
Received
2024-09-04 07:47
Peer-Review Started
2024-09-04 07:47
To Make the First Decision
Return for Revision
2024-11-18 09:18
Revised
2024-11-30 09:00
Second Decision
2024-12-17 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-12-17 08:48
Articles in Press
2024-12-17 08:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-01-13 01:49
Publish the Manuscript Online
2025-01-21 09:22
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma
Manuscript Source Invited Manuscript
All Author List Ying Huang, Xi-Ye Wang, Jia-Yue Huang and Zheng-Wei Huang
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 82104070
Guangdong Universities Keynote Regions Special Funded Project No. 2022ZDZX2002
Corresponding Author Zheng-Wei Huang, Associate Professor, PhD, College of Pharmacy, Jinan University, No. 855 East Xingye Dadao, Panyu District, Guangzhou 511443, Guangdong Province, China. huangzhengw@jnu.edu.cn
Key Words Human β-defensin-1; Immunoliposomes; Colon cancer; SW620; Autophagy
Core Tip Nanotechnology is a cost-effective strategy for addressing the druggable properties of proteins. We propose an immunoliposome system that improves the stability, bioavailability and targeting properties of human β-defensin-1 (hBD-1), which will support its clinical translation. Our strategy is highly effective and may lead to positive clinical trials and large-scale production. We consider immunoliposomes to be suitable nanovesicles for enhancing the drug properties of hBD-1 and warrant further basic and translational research.
Publish Date 2025-01-21 09:22
Citation <p>Huang Y, Wang XY, Huang JY, Huang ZW. Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma. <i>World J Clin Oncol</i> 2025; 16(3): 101098</p>
URL https://www.wjgnet.com/2218-4333/full/v16/i3/101098.htm
DOI https://dx.doi.org/10.5306/wjco.v16.i3.101098
Full Article (PDF) WJCO-16-101098-with-cover.pdf
Manuscript File 101098_Auto_Edited_083255.docx
Answering Reviewers 101098-answering-reviewers.pdf
Audio Core Tip 101098-audio.m4a
Conflict-of-Interest Disclosure Form 101098-conflict-of-interest-statement.pdf
Copyright License Agreement 101098-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 101098-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate 101098-non-native-speakers.pdf
Peer-review Report 101098-peer-reviews.pdf
Scientific Misconduct Check 101098-scientific-misconduct-check.png
Scientific Editor Work List 101098-scientific-editor-work-list.pdf
CrossCheck Report 101098-crosscheck-report.pdf